Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | 19-28z/IL-18 CAR-T cells |
Trade Name | |
Synonyms | |
Drug Descriptions |
19-28z/IL-18 CAR-T cells are T-lymphocytes engineered to express IL-18 and a chimeric antigen receptor (CAR) targeting CD19, which may lead to enhanced antitumor immune response and inhibition of tumor growth (PMID: 29768210). |
DrugClasses | CD19 Immune Cell Therapy 62 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
19-28z/IL-18 CAR-T cells | 19-28z/IL-18 CAR-T cells | 0 | 1 |